The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis
Open accessAbstract
BACKGROUND AND METHODS: Osteoporosis is a recognized complication of corticosteroid therapy. Whether it can be prevented is not known. We conducted a 12-month, randomized, placebo-controlled study of intermittent etidronate (400 mg per day for 14 days) followed by calcium (500 mg per day for 76 days), given for four cycles, in 141 men and women (age, 19 to 87 years) who had recently begun high-dose corticosteroid therapy. The primary outcome measure was the difference in the change in the bone density of the lumbar spine between the groups from base line to week 52. Secondary measures included changes in the bone density of the femoral neck, trochanter, and radius and the rate of new vertebral fractures. RESULTS: The mean (+/-SE) bone density of the lumbar spine and trochanter in the etidronate group increased 0.61 +/- 0.54 and 1.46 +/- 0.67 percent, respectively, as compared with decreases of 3.23 +/- 0.60 and 2.74 +/- 0.66 percent, respectively, in the placebo group. The mean differences between the groups after one year were 3.72 +/- 0.88 percentage points for the lumbar spine (P = 0.02) and 4.14 +/- 0.94 percentage points for the trochanter (P = 0.02). The changes in the femoral neck and the radius were not significantly different between the groups. There was an 85 percent reduction in the proportion of postmenopausal woman with new vertebral fractures in the etidronate group as compared with the placebo group (1 of 31 patients vs. 7 of 32 patients, P = 0.05), and the etidronate-treated postmenopausal women also had significantly fewer vertebral fractures per patient (P = 0.04). CONCLUSIONS: Intermittent etidronate therapy prevents the loss of vertebral and trochanteric bone in corticosteroid-treated patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1968) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a067150 · Cited by 1,349
Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management
Lukert, B. P., & Raisz, L. G. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-352 · Cited by 1,066
Garnero, P. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.6.1693 · Cited by 707
Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin
Sambrook, P., Birmingham, J., Kelly, P., Kempler, S., Nguyen, T., Pocock, N., & Eisman, J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282404 · Cited by 520
Suzuki, Y., Ichikawa, Y., Saito, E., & Homma, M. (1983) · Metabolism · doi:10.1016/0026-0495(83)90221-4 · Cited by 363
Chesnut, C. H., Bell, N. H., Clark, G. S., Drinkwater, B. L., English, S. C., Johnston, C. C., Notelovitz, M., Rosen, C., Cain, D. F., Flessland, K. A., et al. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00387-7 · Cited by 282
R�egsegger, P., Medici, T. C., & Anliker, M. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00542348 · Cited by 245
Dempster, D. W., Arlot, M. A., & Meunier, P. J. (1983) · Calcified Tissue International · doi:10.1007/bf02405069 · Cited by 233
INTERMITTENT CYCLICAL ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED BONE LOSS
Mulder, H., & Struys, A. (1994) · Lara D. Veeken · doi:10.1093/rheumatology/33.4.348 · Cited by 155
Healey, J. H., Paget, S. A., Williams-Russo, P. G., Szatrowski, T. P., Schneider, R. J., Spiera, H., Mitnick, H. J., Aleš, K. L., & Schwartzberg, P. (1996) · Calcified Tissue International · doi:10.1007/bf02529727 · Cited by 128
Cited by
Kornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Papaioannou, A., Morin, S., Cheung, A. M., Atkinson, S., Brown, J. P., Feldman, S., Hanley, D. A., Hodsman, A., Jamal, S. A., Kaiser, S. M., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.100771 · Cited by 1,749
Self-citationLiu, D., Ahmet, A., Ward, L., Krishnamoorthy, P., Mandelcorn, E. D., Leigh, R., Brown, J. P., Cohen, A., & Kim, H. (2013) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-9-30 · Cited by 1,268
Self-citationAlendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
Self-citation
Metadata
- Authors
- Adachi, J. D., Bensen, W. G., Brown, J., Hanley, D., Hodsman, A., Josse, R., Kendler, D. L., Lentle, B., Olszynski, W., Ste.-Marie, L.-G., Tenenhouse, A., Chines, A. A., Jovaisas, A., Sturtridge, W. C., Anastassiades, T. P., Hanly, J. G., Pope, J. E., Dias, R., Horowitz, Z. D., & Pack, S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1997-08-07
- Volume
- 337
- Issue
- 6
- Pages
- 382-388
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2335475908
- Cited by
- 685
- References
- 13
- FWCI
- 67.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis. https://app.cochat.ai/papers/10.1056/nejm199708073370603
- The paper
- Adachi, J. D., Bensen, W. G., Brown, J., Hanley, D., Hodsman, A., Josse, R., Kendler, D. L., Lentle, B., Olszynski, W., Ste.-Marie, L.-G., Tenenhouse, A., Chines, A. A., Jovaisas, A., Sturtridge, W. C., Anastassiades, T. P., Hanly, J. G., Pope, J. E., Dias, R., Horowitz, Z. D., & Pack, S. (1997). Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis. New England Journal of Medicine. https://doi.org/10.1056/nejm199708073370603
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.